As a follow-up to our previous episode focused on innovative Blood Collection Devices from Tasso, Inc., Dr. Matthew Fedoruk joins us to discuss how Tasso’s blood collection devices are being used in anti-doping and the state of the science of what we can detect with these devices for anti-doping purposes. He covers important benefits of these devices, current limitations, and some of the key milestones and future directions for implementation in anti-doping testing. Dr. Fedoruk is Chief Science Officer at the U.S. Anti-Doping Agency (USADA), and he is also Co-Chair of the Partnership for Clean Competition’s Scientific Advisory Board.
By Partnership for Clean Competition|2024-02-20T07:01:10-07:00February 20th, 2024|Categories: Podcast|Comments Off on 120 – The State of the Science Surrounding Blood Collection Devices from Tasso, Inc. – Matthew Fedoruk, PhD
Collecting blood samples is critical in anti-doping testing and a variety of clinical applications such as diagnostics and disease monitoring. However, traditional blood testing approaches can be a major pain point for athletes, sport organizations, patients, and their care teams. Tasso, Inc. is a company developing innovative products to improve the user experience surrounding blood collection. In this episode, Dr. Erwin Berthier and RJ Asplund describe Tasso’s current devices and how they work, the benefits of these products, and how their work is helping advance anti-doping. Erwin is Co-Founder and Chief Technology Officer and RJ is Vice President of Commercial at Tasso, Inc.